PET in face and neck tumours.
FDG-PET is a useful tool in the imaging of head and neck tumours. It can be used to stage the primary tumour, to assess response to therapy and most importantly for the detection of recurrent tumour. The advantages and limitations of this technique are discussed in this article.
Rankin
Sheila C
SC
Guy's and St. Thomas' Foundation Trust, London, UK. sheila.rankin@gstt.sthames.nhs.uk
D005153:Facial Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D006801:Humans; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging; D008279:Magnetic Resonance Imaging; D009362:Neoplasm Metastasis / Q000000981:diagnostic imaging; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging; D009367:Neoplasm Staging / Q000379:methods; D016609:Neoplasms, Second Primary / Q000000981:diagnostic imaging; D009382:Neoplasms, Unknown Primary / Q000000981:diagnostic imaging; D049268:Positron-Emission Tomography / Q000379:methods; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18